BioNexus Gene Lab Corp (BGLC) Q1 2025 Annual Earnings
BGLC·Reported May 15, 2025·Before market open
BioNexus Gene Lab Corp reported Q1 2025 revenue of $2.1M (-10.3% YoY). Diluted EPS came in at $-0.03 (+83.3% YoY).
Revenue
$2.1M
Diluted EPS
$-0.03
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about BioNexus Gene Lab Corp's Q1 2025 earnings report.
BioNexus Gene Lab Corp (BGLC) reported Q1 2025 earnings on May 15, 2025 before market open.
BioNexus Gene Lab Corp reported revenue of $2.1M and diluted EPS of $-0.03 for Q1 2025.
Compared to the same quarter a year prior, revenue declined 10.3% from $2.4M a year earlier and diluted EPS grew 83.3% from $-0.18.
You can read the 10-K periodic report (0001477932-25-002725) directly on SEC EDGAR. The filing index links above go to sec.gov.